366 related articles for article (PubMed ID: 18612052)
1. Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study.
Xu J; Schwartz K; Bartoces M; Monsur J; Severson RK; Sobel JD
J Am Board Fam Med; 2008; 21(4):261-8. PubMed ID: 18612052
[TBL] [Abstract][Full Text] [Related]
2. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics.
Pirotta MV; Garland SM
J Clin Microbiol; 2006 Sep; 44(9):3213-7. PubMed ID: 16954250
[TBL] [Abstract][Full Text] [Related]
3. Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.
Rocha RM; Zanni PC; de Souza Bonfim-Mendonça P; Gimenes F; Alczuk SS; Svidzinski TI; Consolaro ME
Int Urogynecol J; 2016 May; 27(5):773-80. PubMed ID: 26564224
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India.
Ahmad A; Khan AU
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):68-71. PubMed ID: 19261369
[TBL] [Abstract][Full Text] [Related]
5. Detection of Candida species by PCR in self-collected vaginal swabs of women after taking antibiotics.
Tabrizi SN; Pirotta MV; Rudland E; Garland SM
Mycoses; 2006 Nov; 49(6):523-4. PubMed ID: 17022774
[TBL] [Abstract][Full Text] [Related]
6. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
Ray D; Goswami R; Dadhwal V; Goswami D; Banerjee U; Kochupillai N
J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922
[TBL] [Abstract][Full Text] [Related]
7. Re: Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study.
Tandon S
J Am Board Fam Med; 2009; 22(2):223; author reply 223. PubMed ID: 19264949
[No Abstract] [Full Text] [Related]
8. Post-menopausal recurrent vaginal candidiasis: effect of hysterectomy on response to treatment, type of colonization and recurrence rates post-treatment.
Ventolini G; Baggish MS
Maturitas; 2005 Jul; 51(3):294-8. PubMed ID: 15978973
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
10. Vulvovaginal candidiasis in women who have sex with women.
Bailey JV; Benato R; Owen C; Kavanagh J
Sex Transm Dis; 2008 Jun; 35(6):533-6. PubMed ID: 18418293
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia.
Amouri I; Sellami H; Borji N; Abbes S; Sellami A; Cheikhrouhou F; Maazoun L; Khaled S; Khrouf S; Boujelben Y; Ayadi A
Mycoses; 2011 Sep; 54(5):e499-505. PubMed ID: 21039942
[TBL] [Abstract][Full Text] [Related]
12. The risks of symptomatic vaginal candidiasis after oral antibiotic therapy.
MacDonald TM; Beardon PH; McGilchrist MM; Duncan ID; McKendrick AD; McDevitt DG
Q J Med; 1993 Jul; 86(7):419-24. PubMed ID: 8210296
[TBL] [Abstract][Full Text] [Related]
13. Vaginitis in a gynecologic practice in Israel: causes and risk factors.
Dan M; Kaneti N; Levin D; Poch F; Samra Z
Isr Med Assoc J; 2003 Sep; 5(9):629-32. PubMed ID: 14509151
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and management of non-albicans vaginal candidiasis.
Hettiarachchi N; Ashbee HR; Wilson JD
Sex Transm Infect; 2010 Apr; 86(2):99-100. PubMed ID: 20332368
[TBL] [Abstract][Full Text] [Related]
15. [Vulvovaginal candidiasis in pregnant women with impaired tolerance for glucose].
Deng QS; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):374-6. PubMed ID: 17697596
[TBL] [Abstract][Full Text] [Related]
16. Associations with asymptomatic colonization with Candida in women reporting past vaginal candidiasis: an observational study.
Watson CJ; Fairley CK; Grando D; Garland SM; Myers SP; Pirotta M
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):376-9. PubMed ID: 23639675
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS; Skokos CK
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
[TBL] [Abstract][Full Text] [Related]
18. Vaginal colonization with Candida spp. in human immunodeficiency virus-infected women: a cohort study.
Beltrame A; Matteelli A; Carvalho AC; Saleri N; Casalini C; Capone S; Patroni A; Manfrin M; Carosi G
Int J STD AIDS; 2006 Apr; 17(4):260-6. PubMed ID: 16595050
[TBL] [Abstract][Full Text] [Related]
19. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
Donders G; Bellen G; Byttebier G; Verguts L; Hinoul P; Walckiers R; Stalpaert M; Vereecken A; Van Eldere J
Am J Obstet Gynecol; 2008 Dec; 199(6):613.e1-9. PubMed ID: 18976735
[TBL] [Abstract][Full Text] [Related]
20. A 5-year (2000-2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria.
Paulitsch A; Weger W; Ginter-Hanselmayer G; Marth E; Buzina W
Mycoses; 2006 Nov; 49(6):471-5. PubMed ID: 17022763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
